Last checked at 18 Nov 2021 15:03
REPEAT: Marks Electrical sees significant interim revenue growth
REPEAT: Marks Electrical sees significant interim revenue growth
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Marks Electric Share News (MRK)
MRK Share
Price
MRK Share
News
MRK Share
Chat
MRK Share
Trades9
MRK
Live RNS
MRK Share
Charts
MRK Level 2
Console
MRK Live
Share Price
MRK Broker
Ratings
MRK Directors
Deals
MRK Financial
Diary
MRK
Fundamentals
MRK Short
Positions
MRK
Media
Marks Electric Information
Share Price Information for Marks Electric (MRK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
69.00
Bid:
68.00
Ask:
70.00
Change:
0.50 (0.73%)
Spread:
2.00 (2.941%)
Open:
68.50
High:
69.00
Low:
66.00
Prev. Close:
68.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 Nov 2021 14:36
IN BRIFE: Marks Electrical sees significant interim revenue growth
IN BRIFE: Marks Electrical sees significant interim revenue growth
Read more18 Nov 2021 11:42
Marks Electrical makes market share gains, reaches record revenue
(Sharecast News) - Online appliance retailer Marks Electrical Group reported "strong" first half revenue growth of 78% on Thursday, to £37.5m.
Read more11 Nov 2021 15:51
UK earnings, trading statements calendar - next 7 days
UK earnings, trading statements calendar - next 7 days
Read more5 Nov 2021 14:31
IN BRIEF: Marks Electrical commences trading on London's AIM
IN BRIEF: Marks Electrical commences trading on London's AIM
Read more2 Nov 2021 16:51
IN BRIEF: Marks Electrical's set to start trading on AIM on November 5
IN BRIEF: Marks Electrical's set to start trading on AIM on November 5
Read more3 Apr 2018 12:00
FOCUS-High-flying biotech Loxo tempers bullish view for cancer drug
By Bill Berkrot STAMFORD, Connecticut, April 3 (Reuters) - In record time, Loxo Oncology developed a novel drug for a wide variety of tumors that share a rare mutation.
Read more27 Mar 2018 13:57
Reuters Health News Summary
Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a
Read more27 Mar 2018 13:57
Reuters Health News Summary
Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholesterol or a genetic predisposition a
Read more26 Mar 2018 21:56
Reuters Health News Summary
Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a
Read more26 Mar 2018 21:56
Reuters Health News Summary
Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical Holding said its acute two a
Read more26 Mar 2018 13:56
Reuters Health News Summary
Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among
Read more26 Mar 2018 13:56
Reuters Health News Summary
Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among
Read more26 Mar 2018 07:23
UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success
ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail, the Swiss trial
Read more21 Mar 2018 07:00
FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division
* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, promise lies from Ben March 21
Read more